Tesamorelin vs MK-677 compared: how each works, FDA approval status, dosing, side effects, and what they can and cannot do. Read this before you choose.
Tesamorelin and MK-677 both raise growth hormone and IGF-1 levels, but they are not interchangeable. Tesamorelin is an FDA-approved injectable prescription drug for HIV-associated lipodystrophy, while MK-677 is an oral research chemical that has never been approved for human use. Neither is approved for muscle growth or general weight loss in the United States.
What Is Tesamorelin?
Tesamorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH). Rather than supplying growth hormone from the outside, it signals the pituitary gland to release the body's own growth hormone in natural pulses.
The FDA approved tesamorelin in 2010 under the brand name Egrifta, and the concentrated Egrifta SV formulation came later. Its only approved indication is reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
- Type: GHRH analog peptide.
- Route: Subcutaneous injection, once daily.
- Prescription dose: 1.4 mg (Egrifta SV) or 2 mg daily.
- Evidence base: Randomized controlled trials in adults with HIV and excess visceral fat.
What Is MK-677?
MK-677, also known as ibutamoren or Nutrobal, is an oral non-peptide ghrelin receptor agonist. It mimics the hunger hormone ghrelin, which triggers growth hormone release, and it reliably increases both IGF-1 and appetite.
Merck developed MK-677 in the 1990s and studied it in older adults, but the drug was never approved for any human medical use. Today it is sold online as a research chemical, usually with a label stating it is not for human consumption.
- Type: Non-peptide ghrelin mimetic.
- Route: Oral capsule, tablet, liquid, or powder.
- Half-life: Roughly 24 hours, so a single dose acts far longer than injected peptides.
- Evidence base: Small, short-term human studies, mostly in older adults.
Tesamorelin vs MK-677: Side-by-Side Comparison
The mk677 vs tesamorelin question is really about two different routes, two different mechanisms, and two very different regulatory positions. The table below summarizes the practical differences.
| Feature | Tesamorelin | MK-677 |
|---|---|---|
| Compound class | GHRH analog peptide | Ghrelin receptor agonist (non-peptide) |
| Administration | Subcutaneous injection | Oral |
| FDA approval | Yes, for HIV-associated lipodystrophy | None |
| Prescription required | Yes | No, sold as a research chemical |
| Half-life | About 30 minutes | About 24 hours |
| Appetite effects | Minimal | Marked increase |
| Common side effects | Injection-site reactions, joint pain, swelling, elevated IGF-1 | Appetite increase, water retention, fatigue, higher fasting glucose |
| Human data | Large randomized trials | Small, short-term trials |
Side Effects and Safety Considerations
Both compounds raise IGF-1, and elevated IGF-1 over long periods is a legitimate concern that researchers continue to study. Anyone using either compound should be monitored by a healthcare professional, especially if they have diabetes, prediabetes, or a personal or family history of cancer.
Tesamorelin
Reported side effects include injection-site reactions, muscle and joint pain, peripheral edema, and increases in IGF-1 and blood sugar. Tesamorelin is contraindicated during pregnancy, in people with active malignancy, and in those with pituitary tumors or pituitary gland disruption.
MK-677
The most consistent effects in human studies were increased appetite, water retention, and reduced insulin sensitivity. Some users report lethargy, numbness, or vivid dreams, and elevated fasting glucose is a recurring finding. Long-term safety data in healthy adults do not exist.
Neither compound is a cure for obesity, aging, or hormonal deficiency, and self-dosing with unregulated products carries real risk.
Regulatory and Legal Status in the US
Tesamorelin is a prescription-only medicine. Using it for body composition outside its approved indication is an off-label decision that a physician must make and supervise.
MK-677 is not a dietary supplement and has no approved medical use. Products sold online are not verified for identity, purity, or dose, and importing them for personal use occupies a legal gray area.
How Tesamorelin Compares to Other GH Peptides
If you are weighing tesamorelin vs sermorelin vs cjc-1295, the key distinction is that only tesamorelin carries an FDA approval, and that approval is narrow. Sermorelin and CJC-1295 are not FDA-approved for body composition or anti-aging purposes.
Researchers comparing cjc-1295 ipamorelin vs tesamorelin tend to focus on injection frequency and how closely each compound mimics the body's natural growth hormone rhythm. CJC-1295 lasts much longer than tesamorelin, while ipamorelin acts through a separate ghrelin-related receptor.
On the specific question of tesamorelin vs cjc 1295 for muscle growth, the honest answer is that neither is approved for building muscle and human data on muscle outcomes are limited for both.
People who want to target fat without raising growth hormone often look at aod 9604 vs tesamorelin instead. AOD-9604 is a fragment of growth hormone that does not stimulate GH release, so its mechanism and risk profile are different from tesamorelin's.
The Bottom Line
Tesamorelin is a regulated, injectable prescription drug with a narrow FDA-approved indication and a comparatively strong clinical evidence base. MK-677 is an unapproved oral research chemical with a long duration of action, a notable appetite effect, and limited human safety data.
MK-677 is not FDA-approved for any human use, and tesamorelin is not approved for muscle growth or general weight loss. Anyone considering either compound should discuss the risks with a licensed healthcare professional rather than relying on forum reports or vendor marketing.
Frequently Asked Questions
Is MK-677 the same as tesamorelin?
No. Tesamorelin is a peptide GHRH analog given by injection and approved by the FDA for HIV-associated lipodystrophy, while MK-677 is an oral non-peptide ghrelin receptor agonist that has never been approved for human use. They raise growth hormone through different receptors, have very different half-lives, and produce different side effect profiles.
Is MK-677 legal to buy in the US?
MK-677 is not an FDA-approved drug and is not a legal dietary supplement. It is typically sold online as a research chemical labeled 'not for human consumption,' so purity and dose are unverified and personal import sits in a legal gray area. MK-677 is also banned by WADA for competitive athletes.
Does tesamorelin build muscle?
Tesamorelin is not approved for muscle growth. Its FDA-approved indication is reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy, and the clinical trials measured fat distribution rather than muscle mass. Any lean-mass effect would be indirect and modest, and off-label use requires a prescription and medical monitoring.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.